Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

8/8/2020 Pharmaceutical Drug Production in Russia (First Half of 2020)

Between January and June 2020, Russia manufactured 232 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is in monetary terms (rubles) 24% higher than in 2019. The dynamics in physical terms (units) are +18.3%, with the manufacture volume of 2.45 bln units. If calculated in minimum dosage units (MDU), Russia manufactured 42.7 bln MDUs, with the dynamics of +21.2%.

8/7/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Only 11% of Russian Doctors Agree with the Official Statistics Showing Decreased Rates of COVID-19 Incidence

44% of Russian doctors believe that the COVID-19 situation is stable, but at the same time note that the morbidity rates have not significantly reduced, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. This opinion is shared by 60% of the respondents residing in Moscow and St. Petersburg and by only 37% of those residing in the other regions. However, no one expects complete unanimity, because the epidemiological situation obviously differs from region to region.

7/31/2020 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (June and Q1 – Q2 2020)

Between January and June 2020, Russia imported 12.2 bln RUB worth of pharmaceutical drugs for clinical trials (CT) (customs clearance and VAT included), which is in monetary terms (rubles) 49% higher than in 2019. The dynamics in physical terms (units) are also positive, +40%, with the import volume of 472 thousand units.

7/29/2020 Veterinary API Import to Russia (First Half of 2020)

Between January and June 2020, Russia imported 1.17 bln RUB worth of veterinary APIs (customs clearance and VAT included), which is monetary terms (rubles) 7% lower than in 2019. The dynamics in physical terms (kilograms) are -25%, with the volume of 412 tons.

7/28/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Pharmacists Consider iHerb a Serious Competitor

49% of pharmacists see the growing iHerb service as an absolute danger, because more and more people buy OTC drugs online, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. However, it is obvious that the respondents also meant other online marketplaces, since the Russian market has a number of specialized and non-specialized players selling dietary supplements, cosmetic products, and other pharmacy products. Another 4% of the pharmacists note that the consumer is basically the same both online and offline, and their budget is very limited due to the current economic conditions.

7/28/2020 Import of Veterinary Drugs and Feed Supplements to Russia (June and First Half of 2020)

Between January and June 2020, Russia imported 15.2 bln RUB worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms (rubles) 5% higher than in 2019, and 21.2 bln RUB worth of feed supplements, with the dynamics of +17% in monetary terms.

7/27/2020 Pharmaceutical Drug Import to Russia (June and First Half of 2020)

Between January and June 2020, Russia imported 269.3 bln RUB worth of ready-made pharmaceuticals (customs clearance and VAT included), which is in monetary terms (rubles) 2% lower than in 2019. The dynamics were even lower in May 2020 (-27%), but in June, the importers sought to have their stocks replenished after it became clear that the launch of the labeling system would not be postponed again. As for in-bulk pharmaceutical drugs, the import volume amounted to 64.5 bln RUB, with the dynamics of +20%.

7/27/2020 API Import to Russia (June and First Half of 2020)

Between January and June 2020, Russia imported 87.3 bln RUB worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 54% higher than in 2019. In physical terms, the import volume amounted to 7.3 thousand tons of APIs, including commercial ones, with the dynamics of +25%.

7/23/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (June 2020)

Between January and June 2020, the sales of veterinary drugs in the retail market amounted to 10.7 bln RUB (retail prices, VAT included), with the dynamics in monetary terms (rubles) of +1.3%. In physical terms (minimum dosage units), the market volume is 92.2 mln MDUs, with the dynamics of +1.1%.

7/9/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 59% of Russian Doctors Consider Telemedicine Possible

More than a third (35%) of doctors are adamantly opposed to the idea of telemedicine, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.